Cargando…
Current status and advances of fish vaccines in Malaysia
Fish diseases have a significant negative influence on the Malaysian aquaculture industry. Since the 1980s, the sector has grown in size, which has resulted in a rise in the prevalence of infectious outbreaks affecting both freshwater and marine cultured fish species. Demand for commercially availab...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Veterinary World
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980389/ https://www.ncbi.nlm.nih.gov/pubmed/35400970 http://dx.doi.org/10.14202/vetworld.2022.465-482 |
_version_ | 1784681381526241280 |
---|---|
author | Ridzuan, Mohd Syafiq Mohammad Abdullah, Azila Ramly, Rimatulhana Mansor, Nur Nazifah Ramli, Norazsida Firdaus-Nawi, Mohd. |
author_facet | Ridzuan, Mohd Syafiq Mohammad Abdullah, Azila Ramly, Rimatulhana Mansor, Nur Nazifah Ramli, Norazsida Firdaus-Nawi, Mohd. |
author_sort | Ridzuan, Mohd Syafiq Mohammad |
collection | PubMed |
description | Fish diseases have a significant negative influence on the Malaysian aquaculture industry. Since the 1980s, the sector has grown in size, which has resulted in a rise in the prevalence of infectious outbreaks affecting both freshwater and marine cultured fish species. Demand for commercially available fish vaccinations is predicted to increase as infectious disease outbreaks continue to occur. In Malaysia, aquaculture vaccine research and development (R&D) are still in its infancy, with most efforts concentrating on producing vaccines against bacterial infections, most notably streptococcosis, vibriosis, and motile Aeromonas septicemia. Despite several attempts, no homegrown vaccine has been effectively introduced into the manufacturing pipeline to date. At the moment, only three imported aquatic vaccines have received full permission, a far cry from the 314 and 60 vaccines licensed in the poultry and porcine industries, respectively. This review will describe recent findings regarding the development of aquaculture vaccines for certain fish species and diseases in Malaysia. In our opinion, R&D on fish vaccines is critical to the aquaculture industry’s viability. |
format | Online Article Text |
id | pubmed-8980389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Veterinary World |
record_format | MEDLINE/PubMed |
spelling | pubmed-89803892022-04-08 Current status and advances of fish vaccines in Malaysia Ridzuan, Mohd Syafiq Mohammad Abdullah, Azila Ramly, Rimatulhana Mansor, Nur Nazifah Ramli, Norazsida Firdaus-Nawi, Mohd. Vet World Review Article Fish diseases have a significant negative influence on the Malaysian aquaculture industry. Since the 1980s, the sector has grown in size, which has resulted in a rise in the prevalence of infectious outbreaks affecting both freshwater and marine cultured fish species. Demand for commercially available fish vaccinations is predicted to increase as infectious disease outbreaks continue to occur. In Malaysia, aquaculture vaccine research and development (R&D) are still in its infancy, with most efforts concentrating on producing vaccines against bacterial infections, most notably streptococcosis, vibriosis, and motile Aeromonas septicemia. Despite several attempts, no homegrown vaccine has been effectively introduced into the manufacturing pipeline to date. At the moment, only three imported aquatic vaccines have received full permission, a far cry from the 314 and 60 vaccines licensed in the poultry and porcine industries, respectively. This review will describe recent findings regarding the development of aquaculture vaccines for certain fish species and diseases in Malaysia. In our opinion, R&D on fish vaccines is critical to the aquaculture industry’s viability. Veterinary World 2022-02 2022-02-26 /pmc/articles/PMC8980389/ /pubmed/35400970 http://dx.doi.org/10.14202/vetworld.2022.465-482 Text en Copyright: © Ridzuan, et al. https://creativecommons.org/licenses/by/4.0/Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Article Ridzuan, Mohd Syafiq Mohammad Abdullah, Azila Ramly, Rimatulhana Mansor, Nur Nazifah Ramli, Norazsida Firdaus-Nawi, Mohd. Current status and advances of fish vaccines in Malaysia |
title | Current status and advances of fish vaccines in Malaysia |
title_full | Current status and advances of fish vaccines in Malaysia |
title_fullStr | Current status and advances of fish vaccines in Malaysia |
title_full_unstemmed | Current status and advances of fish vaccines in Malaysia |
title_short | Current status and advances of fish vaccines in Malaysia |
title_sort | current status and advances of fish vaccines in malaysia |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980389/ https://www.ncbi.nlm.nih.gov/pubmed/35400970 http://dx.doi.org/10.14202/vetworld.2022.465-482 |
work_keys_str_mv | AT ridzuanmohdsyafiqmohammad currentstatusandadvancesoffishvaccinesinmalaysia AT abdullahazila currentstatusandadvancesoffishvaccinesinmalaysia AT ramlyrimatulhana currentstatusandadvancesoffishvaccinesinmalaysia AT mansornurnazifah currentstatusandadvancesoffishvaccinesinmalaysia AT ramlinorazsida currentstatusandadvancesoffishvaccinesinmalaysia AT firdausnawimohd currentstatusandadvancesoffishvaccinesinmalaysia |